What do systematic reviews say?

foam dressing vs hydrocapillary dressing

• Foam dressings for venous leg ulcers 2013 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

foam dressing vs hydrocolloid dressing

• Foam dressings for venous leg ulcers 2013 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

foam dressing vs knitted viscose dressing

• Foam dressings for venous leg ulcers 2013 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

polyurethane foam dressing vs hydrocellular foam dressing

• Foam dressings for venous leg ulcers 2013 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Intervention not reported

The review found no eligible studies for this question.

• Chromium picolinate supplementation for overweight or obese adults 2013 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• Self‐monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin 2012 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 523 participants
  Moderate

Intervention not reported

The review found no eligible studies for this question.

• Adenosine‐diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes… 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Interactive computer intervention vs usual care

The review found no eligible studies for this question.

• Interactive computer‐based interventions for weight loss or weight maintenance in overweight or obese people 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Interactive computer intervention vs in‐person interventions

The review found no eligible studies for this question.

• Interactive computer‐based interventions for weight loss or weight maintenance in overweight or obese people 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Momordica charantia for type 2 diabetes mellitus 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression 2012 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 153 participants
  Low

Intervention not reported

• Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression 2012 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 784 participants
  Low

Intervention not reported

The review found no eligible studies for this question.

• Green tea for weight loss and weight maintenance in overweight or obese adults 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Febuxostat 80 mg/day vs placebo

The review found no eligible studies for this question.

• Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Febuxostat 120 mg/day vs placebo

The review found no eligible studies for this question.

• Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Febuxostat 40 mg/day vs allopurinol

The review found no eligible studies for this question.

• Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Febuxostat 80 mg/day vs allopurinol

The review found no eligible studies for this question.

• Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Febuxostat 120 mg/day vs allopurinol

The review found no eligible studies for this question.

• Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Febuxostat 40 mg/day vs placebo

The review found no eligible studies for this question.

• Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Colesevelam for type 2 diabetes mellitus 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found